SEE · As filed with the SEC
Sealed Air cash flow statement, by fiscal year
The statement as Sealed Air presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Cash Flows · USD
| USD | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Dec 31, 2021 | FY2020 Year ended Dec 31, 2020 | FY2019 Year ended Dec 31, 2019 | FY2018 Year ended Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Net earnings | 505,500,000 | 264,700,000 | 341,600,000 | 491,600,000 | 506,800,000 | 502,900,000 | 263,000,000 | 193,100,000 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | 243,600,000 | 240,900,000 | 233,400,000 | 184,600,000 | 186,400,000 | 174,200,000 | 150,800,000 | 131,200,000 |
| Share-based incentive compensation | 39,500,000 | 31,600,000 | 33,000,000 | 50,500,000 | 43,500,000 | 41,700,000 | 32,900,000 | 29,200,000 |
| Profit sharing expense | 24,600,000 | 26,400,000 | 25,400,000 | 23,500,000 | 22,400,000 | 27,800,000 | 24,500,000 | 21,600,000 |
| Charges related to Venezuelan subsidiaries | — | — | — | — | — | — | — | 0 |
| Loss on debt redemption and refinancing activities | 5,800,000 | 6,800,000 | 13,200,000 | 11,200,000 | 18,600,000 | — | — | — |
| Impairment of debt investment | — | — | — | — | 8,000,000 | — | — | — |
| Impairment of debt investment | 0 | 8,500,000 | 0 | 0 | — | — | — | — |
| Provision for allowance for credit losses on trade receivables | 1,100,000 | 1,300,000 | 3,100,000 | 6,200,000 | 2,100,000 | 3,700,000 | 2,500,000 | 2,300,000 |
| Provisions for inventory obsolescence | 22,700,000 | 18,600,000 | 18,300,000 | 19,800,000 | 9,500,000 | 9,000,000 | 7,200,000 | 4,800,000 |
| Deferred taxes, net | 73,300,000 | (16,400,000) | (27,800,000) | (29,700,000) | 37,300,000 | 81,700,000 | (55,000,000) | 10,900,000 |
| Net (gain) loss on disposal/sale of businesses | (64,300,000) | 4,800,000 | 52,500,000 | (700,000) | (59,300,000) | (19,000,000) | 30,700,000 | (42,500,000) |
| Foreign currency losses (gains) | — | — | — | — | — | — | — | 13,700,000 |
| Gain on equity investment | — | — | — | — | (6,600,000) | (15,100,000) | — | — |
| Impairment loss on equity investments, net | — | 0 | 0 | 30,600,000 | — | — | — | — |
| Other non-cash items | 31,700,000 | 27,300,000 | 25,200,000 | 9,800,000 | 9,400,000 | 2,900,000 | 27,200,000 | 11,100,000 |
| Changes in operating assets and liabilities: | ||||||||
| Trade receivables, net | (2,800,000) | (34,100,000) | 73,400,000 | 2,600,000 | (110,900,000) | 27,400,000 | 38,100,000 | (900,000) |
| Inventories, net | 6,200,000 | (4,300,000) | 136,000,000 | (178,500,000) | (165,700,000) | (25,200,000) | 12,400,000 | (61,200,000) |
| Income tax receivable/payable | (64,300,000) | 45,600,000 | (400,000) | (13,600,000) | 45,700,000 | (31,300,000) | 20,900,000 | (16,400,000) |
| Accounts payable | (29,300,000) | 28,100,000 | (122,800,000) | (72,100,000) | 206,100,000 | 800,000 | (37,000,000) | 42,600,000 |
| Customer advance payments | — | — | (15,400,000) | 1,400,000 | 15,100,000 | 10,800,000 | — | — |
| Tax refunds (payments and deposits) to resolve certain prior years' tax matters | 0 | 54,000,000 | 195,000,000 | — | — | — | — | — |
| Other assets and liabilities | (165,300,000) | 24,200,000 | (77,500,000) | 76,100,000 | (58,700,000) | (55,300,000) | (7,100,000) | 88,500,000 |
| Net cash provided by operating activities | 628,000,000 | 728,000,000 | 516,200,000 | 613,300,000 | 709,700,000 | 737,000,000 | 511,100,000 | 428,000,000 |
| Cash flows from investing activities: | ||||||||
| Capital expenditures | (169,500,000) | (220,200,000) | (244,200,000) | (237,300,000) | (213,100,000) | (181,100,000) | (189,700,000) | (168,600,000) |
| Investment in marketable securities | — | — | — | 0 | 0 | 13,900,000 | — | — |
| Proceeds related to sale of businesses and property and equipment, net | — | — | — | 9,400,000 | 89,400,000 | 12,400,000 | — | — |
| Proceeds related to sale of businesses and property and equipment, net | 300,000 | 1,000,000 | 10,200,000 | — | — | — | — | — |
| Businesses acquired in purchase transactions, net of cash acquired | 0 | 4,200,000 | (1,160,700,000) | (9,600,000) | (100,000) | 1,200,000 | (452,800,000) | (68,400,000) |
| Proceeds from sales of property, equipment and other assets | — | — | — | — | — | — | — | 0 |
| Loss from settlement of cross currency swaps | — | — | — | — | — | — | 0 | 0 |
| Impact of sale of Diversey | — | — | — | — | — | — | 0 | (15,300,000) |
| Payments associated with equity investments | — | — | — | — | — | (8,200,000) | 0 | — |
| Investment in marketable securities | — | — | — | — | — | — | (12,500,000) | — |
| (Payments) Proceeds related to sale of business and property and equipment, net | — | — | — | — | — | — | (2,400,000) | 6,800,000 |
| Payments associated with debt, equity, and equity method investments | — | — | — | (10,600,000) | (18,000,000) | — | — | — |
| Settlement of foreign currency forward contracts | — | — | — | 5,100,000 | 8,400,000 | 1,500,000 | (8,200,000) | (11,100,000) |
| (Payments) Proceeds associated with debt, equity, and equity method investments | (600,000) | (1,100,000) | 2,800,000 | — | — | — | — | (7,500,000) |
| Cross-currency swaps | — | — | 1,600,000 | — | — | — | — | — |
| Foreign Currency Forward Contracts | — | — | 12,100,000 | — | — | — | — | — |
| Proceeds of corporate owned life insurance | — | — | 0 | 0 | 7,700,000 | — | — | — |
| Other investing activities | — | — | — | 0 | 0 | 500,000 | 0 | (2,600,000) |
| Proceeds from cross-currency swaps | 5,300,000 | 3,100,000 | — | — | — | — | — | — |
| Settlement of foreign currency forward contracts | 30,900,000 | (19,500,000) | — | — | — | — | — | — |
| Net cash used in investing activities | (133,600,000) | (232,500,000) | (1,378,200,000) | (243,000,000) | (125,700,000) | (159,800,000) | (665,600,000) | (266,700,000) |
| Cash flows from financing activities: | ||||||||
| Net (payments) proceeds of short-term borrowings | (51,600,000) | 5,200,000 | 131,600,000 | 5,500,000 | (5,900,000) | (99,000,000) | (127,500,000) | 224,000,000 |
| Proceeds from cross currency swap | — | — | — | — | — | — | 0 | 0 |
| Proceeds from long-term debt | 15,400,000 | 416,200,000 | 1,833,400,000 | 423,300,000 | 601,500,000 | 0 | 894,900,000 | — |
| Payments of long-term debt | (383,000,000) | (710,500,000) | (958,400,000) | (425,000,000) | (610,400,000) | (5,600,000) | (425,000,000) | (1,600,000) |
| Dividends paid on common stock | (119,200,000) | (118,000,000) | (117,900,000) | (118,500,000) | (115,600,000) | (100,400,000) | (99,100,000) | (104,100,000) |
| Repurchases of common stock | 0 | 0 | (79,900,000) | (280,200,000) | (403,100,000) | (33,000,000) | (67,300,000) | (582,600,000) |
| Payments for debt modification/extinguishment costs and other | (5,800,000) | (7,600,000) | (22,300,000) | (15,200,000) | (17,000,000) | 0 | (15,500,000) | (6,100,000) |
| Impact of tax withholding on share-based compensation | (13,600,000) | (9,900,000) | (21,800,000) | (26,600,000) | (14,800,000) | (11,600,000) | (10,800,000) | (7,900,000) |
| Principal payments related to financing leases | (9,800,000) | (8,200,000) | (9,000,000) | (10,000,000) | (10,500,000) | (11,600,000) | (9,300,000) | — |
| Other financing activities | — | — | — | 0 | 0 | (500,000) | (500,000) | 0 |
| Net cash (used in) provided by financing activities | (567,600,000) | (432,800,000) | 755,700,000 | (446,700,000) | (575,800,000) | (261,700,000) | 139,900,000 | 478,300,000 |
| Effect of foreign currency exchange rate changes on cash and cash equivalents | — | — | — | — | 4,100,000 | (29,200,000) | 5,300,000 | (5,300,000) |
| Effect of foreign currency exchange rate changes on cash and cash equivalents | 46,700,000 | (37,000,000) | (3,700,000) | (28,500,000) | — | — | — | — |
| Cash and cash equivalents | 371,800,000 | 346,100,000 | 456,100,000 | 561,000,000 | 548,700,000 | 262,400,000 | 271,700,000 | 594,000,000 |
| Restricted cash and cash equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Cash, cash equivalents, and restricted cash, beginning of period | 371,800,000 | 346,100,000 | 456,100,000 | 561,000,000 | 548,700,000 | 262,400,000 | 271,700,000 | 594,000,000 |
| Net change during the period | — | — | — | — | — | — | (9,300,000) | (322,300,000) |
| Net change during the period | (26,500,000) | 25,700,000 | (110,000,000) | (104,900,000) | 12,300,000 | 286,300,000 | — | — |
| Cash and cash equivalents | — | 371,800,000 | — | — | — | — | — | — |
| Restricted cash and cash equivalents | — | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Cash, cash equivalents, and restricted cash, end of period | 345,300,000 | 371,800,000 | 346,100,000 | 456,100,000 | 561,000,000 | 548,700,000 | 262,400,000 | 271,700,000 |
| Supplemental Cash Flow Information: | ||||||||
| Interest payments, net of amounts capitalized | 268,500,000 | 284,100,000 | 265,200,000 | 174,500,000 | 175,200,000 | 187,700,000 | 194,900,000 | 191,400,000 |
| Income tax payments, net of cash refunds | — | 109,700,000 | 357,700,000 | 192,200,000 | 112,600,000 | 102,000,000 | 94,700,000 | 155,000,000 |
| Payments related to sale of Diversey | — | — | — | — | — | 0 | 0 | 51,600,000 |
| Restructuring payments including associated costs | 79,800,000 | 58,100,000 | 19,200,000 | 21,500,000 | 27,700,000 | 73,700,000 | 90,900,000 | 12,100,000 |
| Non-cash items: | ||||||||
| Transfers of shares of common stock from treasury for profit-sharing plan contributions | 26,300,000 | 25,400,000 | 23,900,000 | 22,700,000 | 28,000,000 | 24,400,000 | 21,900,000 | 23,500,000 |
| Accrued capital expenditures | 32,400,000 | 33,000,000 | — | — | — | — | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.